Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
American CryoStem Corporation (CRYO)
OTHER OTC:CRYO
American CryoStem (CRYO) Stock Price & Analysis
9 Followers
CRYO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.06 - $0.21
Previous Close$0.07
Volume2.90K
Average Volume (3M)N/A
Market Cap
$53.13K
Enterprise Value$992.11K
Total Cash (Recent Filing)$2.76K
Total Debt (Recent Filing)$941.73K
Price to Earnings (P/E)N/A
Beta3.78
Next Earnings
May 14, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding44,279,279
10 Day Avg. Volume316
30 Day Avg. VolumeN/A
Standard Deviation0.77
R-Squared0.00513
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.02
Price to Sales (P/S)1.25
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-4.37
Enterprise Value/Gross Profit141.39
Enterprise Value/Ebitda-0.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRYO FAQ
What was American CryoStem Corporation’s price range in the past 12 months?
American CryoStem Corporation lowest stock price was $0.06 and its highest was $0.21 in the past 12 months.
What is American CryoStem Corporation’s market cap?
Currently, no data Available
When is American CryoStem Corporation’s upcoming earnings report date?
American CryoStem Corporation’s upcoming earnings report date is May 14, 2018 which is 1984 days ago.
How were American CryoStem Corporation’s earnings last quarter?
Currently, no data Available
Is American CryoStem Corporation overvalued?
According to Wall Street analysts American CryoStem Corporation’s price is currently Overvalued.
Does American CryoStem Corporation pay dividends?
American CryoStem Corporation does not currently pay dividends.
What is American CryoStem Corporation’s EPS estimate?
American CryoStem Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does American CryoStem Corporation have?
American CryoStem Corporation has 44,279,278 shares outstanding.
What happened to American CryoStem Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of American CryoStem Corporation?
Currently, no hedge funds are holding shares in CRYO
---
American CryoStem Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
American CryoStem Corporation
American CryoStem Corp. is engaged in the development, market, and licenses patented adipose tissue-based cellular technologies, bio-materials, and related proprietary services. It focuses on clinical processing, commercial bio-banking, and application development for adipose tissue and adipose-derived stem cells; and also provides contract manufacturing services to physicians and other medical professionals that perform tissue transfer and other cellular therapy services, as well as offers professional services, including sterility, viability, cellular density, and growth assay analysis. The company was founded by Anthony Francis Dudzinski on November 18, 2008 and is headquartered in Eatontown, NJ.
---
Aytu BioScience
―
Arbutus Biopharma
―
Adverum Biotechnologies
―
Arcturus Therapeutics
―
---